Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 676

Similar articles for PubMed (Select 16569543)

2.

Benefit of cardiac resynchronization in elderly patients: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.

Kron J, Aranda JM Jr, Miles WM, Burkart TA, Woo GW, Saxonhouse SJ, Sears SF Jr, Conti JB.

J Interv Card Electrophysiol. 2009 Aug;25(2):91-6. doi: 10.1007/s10840-008-9330-2. Epub 2009 Jan 19.

PMID:
19152106
3.

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR; Multicenter InSync ICD II Study Group.

Circulation. 2004 Nov 2;110(18):2864-8. Epub 2004 Oct 25.

4.

Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study.

Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA Jr, Curtis AB.

J Interv Card Electrophysiol. 2005 Mar;12(2):107-13.

PMID:
15744462
7.

Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.

Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP.

J Cardiovasc Electrophysiol. 2006 May;17(5):486-90.

PMID:
16684019
8.

A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial.

Boriani G, Kranig W, Donal E, Calo L, Casella M, Delarche N, Lozano IF, Ansalone G, Biffi M, Boulogne E, Leclercq C; B-LEFT HF study group.

Am Heart J. 2010 Jun;159(6):1052-1058.e1. doi: 10.1016/j.ahj.2010.03.008.

PMID:
20569719
9.

Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.

McAlister FA, Ezekowitz J, Dryden DM, Hooton N, Vandermeer B, Friesen C, Spooner C, Rowe BH.

Evid Rep Technol Assess (Full Rep). 2007 Jun;(152):1-199. Review.

10.
11.

Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program.

León AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J, Hayes DL, Lieberman R, Petersen-Stejskal S, Wheelan K; MIRACLE Study Program.

J Am Coll Cardiol. 2005 Dec 20;46(12):2348-56.

12.

Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.

Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A.

Ital Heart J. 2004 May;5(5):364-70.

PMID:
15185900
13.

Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).

Landolina M, Lunati M, Gasparini M, Santini M, Padeletti L, Achilli A, Bianchi S, Laurenzi F, Curnis A, Vincenti A, Valsecchi S, Denaro A; InSync/InSync ICD Italian Registry Investigators.

Am J Cardiol. 2007 Sep 15;100(6):1007-12. Epub 2007 Jul 5.

PMID:
17826388
15.

Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.

De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR.

J Card Fail. 2008 Feb;14(1):9-18. doi: 10.1016/j.cardfail.2007.08.003.

PMID:
18226768
16.

Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.

Lepillier A, Piot O, Gerritse B, Copie X, Lavergne T, Paziaud O, Lascault G, Waintraub X, Otmani A, Le Heuzey JY.

Europace. 2009 Jan;11(1):80-5. doi: 10.1093/europace/eun288. Epub 2008 Oct 24.

17.

Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.

Mollema SA, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ.

Am J Cardiol. 2007 Dec 1;100(11):1665-70. Epub 2007 Oct 24.

PMID:
18036366
18.

Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure.

León AR, Abraham WT, Brozena S, Daubert JP, Fisher WG, Gurley JC, Liang CS, Wong G; InSync III Clinical Study Investigators.

J Am Coll Cardiol. 2005 Dec 20;46(12):2298-304.

19.

Cardiac-resynchronization therapy for the prevention of heart-failure events.

Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators.

N Engl J Med. 2009 Oct 1;361(14):1329-38. doi: 10.1056/NEJMoa0906431. Epub 2009 Sep 1.

20.

Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders.

Da Costa A, Thévenin J, Roche F, Faure E, Roméyer-Bouchard C, Messier M, Convert G, Barthélemy JC, Isaaz K.

Heart Rhythm. 2006 Apr;3(4):406-13.

PMID:
16567286
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk